Publications
You may find a full list of publications on Dr. Barbour's Google Scholar page
1. Barbour AJ, Hoag K, Lee VMY, Talos DM, Jensen FE. Seizures drive tau propagation in a tauopathy mouse model. bioRxiv [Preprint]. 2026 Mar 17:2026.03.14.711088. doi: 10.64898/2026.03.14.711088. PMID: 41890022; PMCID: PMC13015319. ​
​
2. Barbour AJ. Screening antiseizure medications to break the cycle between neuronal hyperexcitability and Alzheimer's disease. J Alzheimers Dis. 2025Oct;107(3):994-996. doi: 10.1177/13872877251364556. Epub 2025 Aug 3. PMID:40754800; PMCID: PMC12449591.​
​
3. Barbour AJ, Hoag K, Cornblath EJ, Chavez A, Lucas A, Li X, Zebrowitz S,Hassman C, Vazquez O, Xie SX, Lee EB, Davis KA, Lee VMY, Talos DM, Jensen FE.Hyperactive neuronal networks enhance tau spread in an Alzheimer's disease mouse model. bioRxiv [Preprint]. 2025 Sep 18:2024.12.01.625514. doi:10.1101/2024.12.01.625514. PMID: 39677701; PMCID: PMC11642807.​
​
4. Barbour AJ, Gourmaud S, Lancaster E, Li X, Stewart DA, Hoag KF, Irwin DJ,Talos DM, Jensen FE. Seizures exacerbate excitatory: inhibitory imbalance in Alzheimer's disease and 5XFAD mice. Brain. 2024 Jun 3;147(6):2169-2184. doi:10.1093/brain/awae126. PMID: 38662500; PMCID: PMC11146435.​
​
5. Xing B, Barbour AJ, Vithayathil J, Li X, Dutko S, Fawcett-Patel J, Lancaste rE, Talos DM, Jensen FE. Reversible synaptic adaptations in a subpopulation of murine hippocampal neurons following early-life seizures. J Clin Invest. 2024Jan 16;134(5):e175167. doi: 10.1172/JCI175167. PMID: 38227384; PMCID:PMC10904056.​
​
6. Gourmaud S, Stewart DA, Irwin DJ, Roberts N, Barbour AJ, Eberwine G, O'Brien WT, Vassar R, Talos DM, Jensen FE. The role of mTORC1 activation in seizure-induced exacerbation of Alzheimer's disease. Brain. 2022 Mar 29;145(1):324-339.doi: 10.1093/brain/awab268. PMID: 34264340; PMCID: PMC9126019.​
​
7. Barbour AJ, Nass SR, Hahn YK, Hauser KF, Knapp PE. Restoration of KCC2Membrane Localization in Striatal Dopamine D2 Receptor-Expressing Medium Spiny Neurons Rescues Locomotor Deficits in HIV Tat-Transgenic Mice. ASN Neuro. 2021Jan-Dec;13:17590914211022089. doi: 10.1177/17590914211022089. PMID: 34445881;PMCID: PMC8404672.​
​
8. Song YJ, Xing B, Barbour AJ, Zhou C, Jensen FE. Dysregulation of GABAA Receptor-Mediated Neurotransmission during the Auditory Cortex Critical Period in the Fragile X Syndrome Mouse Model. Cereb Cortex. 2021 Nov 23;32(1):197-215.doi: 10.1093/cercor/bhab203. PMID: 34223875; PMCID: PMC8634585.​
​
9. Marks WD, Paris JJ, Barbour AJ, Moon J, Carpenter VJ, McLane VD, Lark ARS,Nass SR, Zhang J, Yarotskyy V, McQuiston AR, Knapp PE, Hauser KF. HIV-1 Tat and Morphine Differentially Disrupt Pyramidal Cell Structure and Function and Spatial Learning in Hippocampal Area CA1: Continuous versus Interrupted Morphine Exposure. eNeuro. 2021 May 24;8(3):ENEURO.0547-20.2021. doi:10.1523/ENEURO.0547-20.2021. PMID: 33782102; PMCID: PMC8146490.​
​
10. Barbour AJ, Hauser KF, McQuiston AR, Knapp PE. HIV and opiates dysregulateK+- Cl- cotransporter 2 (KCC2) to cause GABAergic dysfunction in primary human neurons and Tat-transgenic mice. Neurobiol Dis.2020 Jul;141:104878. doi: 10.1016/j.nbd.2020.104878. Epub 2020 Apr 25. PMID:32344154; PMCID: PMC7685173.​
​
11. Schier CJ, Marks WD, Paris JJ, Barbour AJ, McLane VD, Maragos WF, McQuistonAR, Knapp PE, Hauser KF. Selective Vulnerability of Striatal D2 versus D1Dopamine Receptor-Expressing Medium Spiny Neurons in HIV-1 Tat Transgenic MaleMice. J Neurosci. 2017 Jun 7;37(23):5758-5769. doi:10.1523/JNEUROSCI.0622-17.2017. Epub 2017 May 4. PMID: 28473642; PMCID:PMC5469310.​
​
12. Opitz A, Legon W, Mueller J, Barbour A, Paulus W, Tyler WJ. Is sham cTBS real cTBS? The effect on EEG dynamics. Front Hum Neurosci. 2015 Jan 8;8:1043.doi: 10.3389/fnhum.2014.01043. PMID: 25620925; PMCID: PMC4287020.​
​
13. Legon W, Sato TF, Opitz A, Mueller J, Barbour A, Williams A, Tyler WJ.Transcranial focused ultrasound modulates the activity of primary somatosensory cortex in humans. Nat Neurosci. 2014 Feb;17(2):322-9. doi: 10.1038/nn.3620. Epub2014 Jan 12. PMID: 24413698.